EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Radiotherapeutic efficacy of gold nanoparticles for high dose‐rate brachytherapy compared to conventional radiotherapy: An in vitro study

Daniel Cecchi, Nolan Jackson, Mehran Goharian, Wayne Beckham, Devika Chithrani

Medical Physics · 2025

DOI: 10.1002/mp.18006 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Medical Physics, 2025. Verfasst von Daniel Cecchi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physics and Astronomy, University of Victoria, Victoria, British Columbia, Canada. Hauptthemen laut MEDLINE: Gold, Brachytherapy, Metal Nanoparticles, Radiation Dosage. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Strategic Initiative, NanoMedicines Innovation Network, Natural Sciences and Engineering Research Council (NSERC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Radiation therapy is a pivotal part of the treatment plan for many cancer patients. Effective dose escalation in the tumour is required to achieve optimal curative results but is hindered by normal tissue toxicity. Gold nanoparticles (GNPs) as radiosensitizers to improve the radiation cross‐section of malignant tissue is one avenue currently being explored to improve therapeutic results. It is hypothesized that at lower incident photon energies, dose enhancement from GNPs should be significantly greater compared to high‐energy irradiations due to a greater photoelectric cross‐section.

Purpose

To assess GNP radiosensitization in vitro during low‐energy, high‐dose‐rate brachytherapy (HDR‐BT) irradiations and compare to the measured radiosensitization from a 6MV photon beam from a clinical linear accelerator (LINAC).

Methods

A novel Solid Water Phantom was developed for uniform irradiations from a common HDR‐BT source (192‐Ir) and verified using EBT‐4 radiochromic film. HeLa (cervical) and PC3 (prostate) monolayer cell cultures were used to represent common HDR‐BT treatment sites. The cells were dosed at 10 µg/mL concentration with functionalized 12 nm spherical GNPs. GNP uptake in the cellular membrane was quantified using live‐cell imaging and a trace element analysis technique. Cell cultures with or without GNPs were irradiated from the 192‐Ir source or clinical 6 MV photon beam from a LINAC to a 200 cGy dose prescription. Cellular viability was measured using a clonogenic assay and DNA double‐strand break (DSB) assay.

Results

Endocytosis of spherical GNPs was confirmed 24 h post‐incubation, resulting in an average of 8.7 × 10 5 GNPs/cell and 6.0 × 10 5 GNPs/cell for HeLa and PC3 cell cultures, respectively. The incorporation of GNPs induced 183% ( p < 0.001) and 364% ( p = 0.01) greater DNA DSBs with HDR‐BT irradiations compared to LINAC irradiations for HeLa and PC3 cells, respectively, after the 200 cGy prescription. GNPs reduced the survival fraction of HeLa and PC3 cells after 2 weeks post‐irradiation by 4.6% ( p < 0.05) and 8.5% ( p < 0.05), respectively, with HDR irradiations compared to LINAC irradiations.

Conclusions

Our results suggest GNP incorporation into HDR‐BT is a viable and effective treatment strategy. As our dosing concentration in this study induced no measurable cellular toxicity, this strategy has the potential to be implemented in clinical scenarios. Ultimately, we believe that incorporating GNPs into radiotherapy workflows can increase radiotherapeutic efficacy, improving the quality of life for cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GoldBrachytherapyMetal NanoparticlesRadiation DosageHumansHeLa CellsRadiotherapy DosagePhantoms, ImagingRadiation-Sensitizing AgentsCell SurvivalPC-3 Cells

Stichwörter der Autor:innen

brachytherapycancernanoparticleradiosensitizerradiotherapytherapeutics

Substanzen

GoldRadiation-Sensitizing Agents

Autor:innen und Institutionen

  • Department of Physics and Astronomy, University of Victoria, Victoria, British Columbia, Canada.
  • British Columbia Cancer, Victoria, British Columbia, Canada.

Förderung

  • Strategic Initiative
  • NanoMedicines Innovation Network
  • Natural Sciences and Engineering Research Council (NSERC)
  • Discovery Grant (DG)
  • NIDCD NIH HHS
  • CIHR
  • Canadian Institutes of Health Research

Zitieren

APA

Cecchi, D., Jackson, N., Goharian, M., Beckham, W., & Chithrani, D. (2025). Radiotherapeutic efficacy of gold nanoparticles for high dose‐rate brachytherapy compared to conventional radiotherapy: An in vitro study. Medical Physics. https://doi.org/10.1002/mp.18006

Vancouver

Cecchi D, Jackson N, Goharian M, Beckham W, Chithrani D. Radiotherapeutic efficacy of gold nanoparticles for high dose‐rate brachytherapy compared to conventional radiotherapy: An in vitro study. Medical Physics. 2025. doi:10.1002/mp.18006

BibTeX
@article{Cecchi2025,
  author = {Cecchi, Daniel and Jackson, Nolan and Goharian, Mehran and Beckham, Wayne and Chithrani, Devika},
  title = {Radiotherapeutic efficacy of gold nanoparticles for high dose‐rate brachytherapy compared to conventional radiotherapy: An in vitro study},
  journal = {Medical Physics},
  year = {2025},
  doi = {10.1002/mp.18006}
}
Kostenlos starten →